你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| 项目编号 | 项目主题 | 项目类型 | 申请状态 | 项目持有者 | 注册时间 |
|---|---|---|---|---|---|
| 40150 | CRYOPROTECTIVE PREMIXES FOR CELLS (GEN YUAN) | II | A | NANJING SANSHENG BIOLOGICAL TECHNOLOGY CO LTD | 2024-06-28 |
| 40146 | BUPROPION HYDROCHLORIDE USP | II | A | IPCA LABORATORIES LTD | 2024-06-28 |
| 40113 | OTILONIUM BROMIDE | II | A | SYMED LABS LTD | 2024-06-28 |
| 40043 | CAP 5 M7G(5')VPPP(5')(2'OMEA)PG 100MM AMMONIUM SOLUTION | II | A | JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTD | 2024-06-28 |
| 40042 | CAP 4 M7G(UNA)(5')PPP(5')(2'OMEA)PG 100MM AMMONIUM SOLUTION | II | A | JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTD | 2024-06-28 |
| 40029 | CARIPRAZINE HYDROCHLORIDE | II | A | HOSTER LABS PRIVATE LTD | 2024-06-28 |
| 39989 | TIRZEPATIDE SIDE CHAIN | II | A | SICHUAN PUKANG PHARMACEUTICAL CO LTD | 2024-06-28 |
| 39977 | 3-(N, N-DIMETHYLAMINOMETHYL)-5-METHYL-2-HEXANONE OXALATE | II | A | AGNO PHARMA | 2024-06-28 |
| 39976 | 6,7-DIMETHOXY-3,4-DIHYDROISOQUINOLINE HYDROCHLORIDE | II | A | AGNO PHARMA | 2024-06-28 |
| 39910 | INSULIN DEGLUDEC | II | A | CHONGQING CHEN'AN BIOPHARMACEUTICAL CO LTD | 2024-06-28 |
| 39902 | SEMAGLUTIDE | II | A | HANGZHOU THINHEAL PHARMA-TECH CO LTD | 2024-06-28 |
| 39901 | LINACLOTIDE | II | A | HANGZHOU THINHEAL PHARMA-TECH CO LTD | 2024-06-28 |
| 39900 | TIRZEPATIDE | II | A | HANGZHOU THINHEAL PHARMA-TECH CO LTD | 2024-06-28 |
| 39768 | LANREOTIDE ACETATE | II | A | DR REDDYS LABORATORIES LTD | 2024-06-28 |
| 37693 | AZILSARTAN KAMEDOXOMIL | II | A | JIANGXI SYNERGY PHARMACEUTICAL CO LTD | 2024-06-28 |
| 37626 | AMPHETAMINE ASPARTATE MONOHYDRATE | II | A | CHATTEM CHEMICALS INC | 2024-06-28 |
| 40166 | TIRZEPATIDE | II | A | SHANGHAI JINGMAI PHARMACEUTICAL SCIENCE & TECHNOLOGY CO LTD | 2024-06-27 |
| 40164 | INDOCYANINE GREEN USP | II | A | MACSEN DRUGS | 2024-06-27 |
| 40161 | (R)-3-(BOC-AMINO) PIPERIDINE | II | A | EMEISHAN HONGSHENG PHARMACEUTICAL CO LTD | 2024-06-27 |
| 40156 | TIRZEPATIDE, NON-STERILE DRUG SUBSTANCE | II | A | HYBIO PHARMACEUTICAL CO LTD | 2024-06-27 |
